| Metric | FY 2025↕ | FY 2024↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.7B | $9.9B | $9.5B | $9.4B | $2.7B | $2.4B | $2.1B | $1.9B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.2B | $0.6B | $1.4B | $1.2B | $0.7B | $0.5B | $0.1B | $0.1B |
| Net Income | $1.6B | $-0.1B | $1.1B | $1.0B | $0.5B | $0.4B | $0.2B | $0.1B |
| EPS (Basic) | $16.34 | $-0.96 | $10.01 | $7.68 | $4.20 | $2.91 | $1.85 | $1.04 |
| EPS (Diluted) | $16.26 | $-0.96 | $9.95 | $7.65 | $4.18 | $2.89 | $1.84 | $1.03 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $29.5B | $27.7B | $29.1B | $38.5B | $35.4B | $32.4B | $32.5B | $30.3B |
| Current Assets | $16.9B | $15.1B | $13.4B | $20.3B | $17.0B | $16.4B | $15.9B | $13.8B |
| Cash & Equivalents | $3.1B | $1.9B | $1.4B | $2.1B | $0.9B | $1.0B | $1.0B | $0.9B |
| Total Liabilities | $21.5B | $19.7B | $19.5B | $27.6B | $25.1B | $22.4B | $22.2B | $20.0B |
| Current Liabilities | $14.0B | $12.6B | $12.6B | $19.3B | $16.1B | $15.3B | $14.8B | $13.4B |
| Stockholders' Equity | $8.0B | $7.9B | $9.5B | $10.8B | $10.2B | $9.9B | $10.1B | $10.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.8B | $1.5B | $1.3B | $1.8B | $1.1B | $1.3B | $0.9B | $0.9B |
| Investing Cash Flow | $0.4B | $0.3B | $-1.1B | $-0.2B | $-1.6B | $-0.3B | $-0.3B | $0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.9B | $-0.5B | $-1.2B | $-0.4B | $0.4B | $-0.9B | $-0.5B | $-0.8B |